CN115232852A - Preparation method of sea buckthorn oligopeptide with ACE (angiotensin converting enzyme) inhibitory activity - Google Patents
Preparation method of sea buckthorn oligopeptide with ACE (angiotensin converting enzyme) inhibitory activity Download PDFInfo
- Publication number
- CN115232852A CN115232852A CN202211087975.3A CN202211087975A CN115232852A CN 115232852 A CN115232852 A CN 115232852A CN 202211087975 A CN202211087975 A CN 202211087975A CN 115232852 A CN115232852 A CN 115232852A
- Authority
- CN
- China
- Prior art keywords
- sea
- sea buckthorn
- peptide
- oligopeptide
- ace
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000003145 Hippophae rhamnoides Nutrition 0.000 title claims abstract description 88
- 108010038807 Oligopeptides Proteins 0.000 title claims abstract description 28
- 102000015636 Oligopeptides Human genes 0.000 title claims abstract description 28
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 240000000950 Hippophae rhamnoides Species 0.000 title claims description 8
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 title description 35
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 title description 35
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 title description 34
- 241000229143 Hippophae Species 0.000 claims abstract description 85
- 239000000843 powder Substances 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 21
- 235000012054 meals Nutrition 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 102000004190 Enzymes Human genes 0.000 claims abstract description 10
- 108090000790 Enzymes Proteins 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 9
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical class C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims abstract description 8
- 108010029541 Laccase Proteins 0.000 claims abstract description 7
- 230000000415 inactivating effect Effects 0.000 claims abstract description 6
- 238000000227 grinding Methods 0.000 claims abstract description 4
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 4
- 101000984728 Chiropsoides quadrigatus Angiotensin-converting enzyme inhibitory peptide Proteins 0.000 claims description 13
- 230000007062 hydrolysis Effects 0.000 claims description 13
- 238000006460 hydrolysis reaction Methods 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000012528 membrane Substances 0.000 claims description 11
- 238000000926 separation method Methods 0.000 claims description 6
- 108090000145 Bacillolysin Proteins 0.000 claims description 5
- 108091005658 Basic proteases Proteins 0.000 claims description 5
- 235000003935 Hippophae Nutrition 0.000 claims description 5
- 108091005507 Neutral proteases Proteins 0.000 claims description 5
- 102000035092 Neutral proteases Human genes 0.000 claims description 5
- 239000000725 suspension Substances 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 229920000049 Carbon (fiber) Polymers 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000001728 nano-filtration Methods 0.000 claims description 3
- 230000007065 protein hydrolysis Effects 0.000 claims description 3
- 230000017854 proteolysis Effects 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims 1
- 238000001694 spray drying Methods 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 47
- 230000005764 inhibitory process Effects 0.000 abstract description 27
- 230000008569 process Effects 0.000 abstract description 7
- 238000004042 decolorization Methods 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 235000013376 functional food Nutrition 0.000 abstract description 4
- 238000001035 drying Methods 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 239000002778 food additive Substances 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 239000002131 composite material Substances 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 235000013373 food additive Nutrition 0.000 abstract description 2
- 239000005417 food ingredient Substances 0.000 abstract description 2
- 238000000751 protein extraction Methods 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 235000001014 amino acid Nutrition 0.000 description 18
- 150000001413 amino acids Chemical class 0.000 description 17
- 102000004196 processed proteins & peptides Human genes 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 102000007079 Peptide Fragments Human genes 0.000 description 7
- 108010033276 Peptide Fragments Proteins 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 230000003301 hydrolyzing effect Effects 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- 102000057297 Pepsin A Human genes 0.000 description 3
- 108090000284 Pepsin A Proteins 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 235000009697 arginine Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 229940111202 pepsin Drugs 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- -1 aromatic amino acid Chemical class 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000004917 carbon fiber Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 125000001165 hydrophobic group Chemical group 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 102400000344 Angiotensin-1 Human genes 0.000 description 1
- 101800000734 Angiotensin-1 Proteins 0.000 description 1
- 102400000345 Angiotensin-2 Human genes 0.000 description 1
- 101800000733 Angiotensin-2 Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- ORWYRWWVDCYOMK-HBZPZAIKSA-N angiotensin I Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 ORWYRWWVDCYOMK-HBZPZAIKSA-N 0.000 description 1
- 229950006323 angiotensin ii Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000003981 capillary liquid chromatography Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000006959 non-competitive inhibition Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Water Supply & Treatment (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention discloses a preparation method of sea buckthorn oligopeptide with ACE inhibitory activity, which comprises the following steps: pretreating raw materials, grinding into thick liquid, carrying out enzymolysis and decoloration, inactivating enzyme, carrying out ultrafiltration, drying and the like. The invention directly takes the seabuckthorn seed meal as the raw material for enzymolysis, combines the steps of protein extraction and enzymolysis, has simpler process and improves the yield of the peptide. The invention adopts the ACE inhibition directional enzymolysis technology, adopts the enzyme preparation of food additive grade, and the process conditions can be applied to the production of functional food ingredients. The decolorization adopts laccase and activated carbon fiber composite treatment, avoids the damage of the traditional chemical decolorization method to the peptide product, and has better decolorization effect. And the preparation condition is mild, the method is simple, and the peptide inhibition activity is high. The obtained ultrafiltrate or powder can be optionally added into other food, and can be used as functional food additive or health product, with wide application.
Description
Technical Field
The invention relates to the technical field of biomass extraction and preparation, in particular to a preparation method of oligopeptide with ACE inhibitory activity.
Background
Sea buckthorn, latin name: hippophae rhamnoides linn. Hippophae rhamnoides is a generic term for plants and their fruits. According to the determination, the sea buckthorn fruit contains active substances such as various vitamins, fatty acids, trace elements, linoleic acid, sea buckthorn flavone, superoxide and the like and various amino acids required by a human body, and the vitamin is called king of vitamin C and life energy. The fructus Hippophae has effects of relieving cough, eliminating phlegm, invigorating stomach, resolving food stagnation, promoting blood circulation and removing blood stasis. Modern medical research shows that seabuckthorn can reduce cholesterol, relieve angina attack and prevent and treat coronary atherosclerotic heart disease. The seed meal of seabuckthorn is the waste of seabuckthorn after extracting seabuckthorn oil, and the seed meal contains various nutrient components such as abundant protein, sugar and edible cellulose, but is only used as feed at present.
ACE Angiotensin converting enzyme (Angiotensin converting enzyme) plays an important role in a human blood pressure regulating system, is widely distributed in each tissue of the whole body, and can convert Angiotensin I into Angiotensin II, so that blood vessel is contracted, and blood pressure is increased. Can also be combined with bradykinin in the blood pressure reducing system to make it inactive, resulting in imbalance of the blood pressure reducing system of human body. Active peptides can bind to the active site of ACE, inhibiting its action.
The prior art lacks of researches on preparation of ACE inhibitory peptide from seabuckthorn seed meal, the preparation process of the active peptide of seabuckthorn seed meal at present is that seabuckthorn protein is extracted firstly, and then polypeptide is prepared by enzymolysis with protein as a raw material, the product process is complex, and the product yield is not high. In addition, the existing process does not solve the problem of pigment residue of peptide products, so that the purity of the products is not high. Therefore, how to improve the yield and purity of the active peptide of the seabuckthorn seed meal and enable the active peptide to have ACE inhibitory activity has important significance for the production and application of the seabuckthorn peptide.
Disclosure of Invention
The invention aims to solve the technical problem of the prior art and provides a preparation method of sea buckthorn oligopeptide with ACE inhibitory activity, which can prepare ACE inhibitory peptide powder, has mild preparation conditions, simple method and high peptide inhibitory activity.
In order to solve the technical problems, the invention adopts the following technical scheme: a preparation method of sea buckthorn oligopeptide with ACE inhibitory activity is characterized by comprising the following steps: the method for obtaining the sea buckthorn ACE inhibitory peptide by taking sea buckthorn seed meal as a raw material through enzymolysis and membrane separation specifically comprises the following steps:
step 3, membrane separation and decoloration: the sea-buckthorn protein hydrolysate is filtered through an ultrafiltration membrane to obtain components below 2000Da, the salt and small molecular weight impurities are removed through a nanofiltration membrane, the separated liquid is decolorized through activated carbon fibers, and the concentrated and spray-dried sea-buckthorn ACE inhibitory peptide is obtained.
In the step 1, the sea buckthorn seed meal is subjected to superfine grinding and is sieved by a 100-mesh sieve to obtain sea buckthorn seed powder, and then the sea buckthorn seed powder is mixed with water according to the weight ratio of 1:10 in the ratio of 10.
In step 2, hydrolyzing with alkaline protease (model number AP 200) for 5h, adding neutral protease (model number EF 108) and laccase, and continuing hydrolyzing for 3h.
In the step 3, the activated carbon fiber is prepared by matching 500L of distilled water with 10 inches of activated carbon fiber, and the decoloring time is 1h.
The invention has the advantages that: 1. in the prior art, protein is extracted from seabuckthorn seed meal by an alkali extraction and acid precipitation process, and then the protein is used as a raw material for enzymolysis, so that partial protein is not precipitated due to different isoelectric points of different proteins, and the waste of protein resources is caused. The invention directly takes the seabuckthorn seed meal as the raw material for enzymolysis, combines the steps of protein extraction and enzymolysis, has simpler process and improves the yield of peptide.
2. The invention adopts an ACE inhibitory directional enzymolysis technology, in the enzymolysis condition, the ACE inhibitory activity is taken as an index, and the active peptide obtained under the enzymolysis condition has better ACE inhibitory activity. Meanwhile, the enzymes adopted in the prior art are mainly biochemical-level enzymes, so that the disclosed preparation process cannot be applied to actual production. The invention is close to the actual production, adopts the enzyme preparation of food additive grade, and the process conditions can be applied to the production of functional food ingredients.
3. The decolorization adopts laccase and activated carbon fiber composite treatment, avoids the damage of the traditional chemical decolorization method to the peptide product, and has better decolorization effect.
In addition, the obtained ultrafiltrate or powder can be optionally added into other foods, can be used as additive of functional foods or health products, and has wide application.
Drawings
FIG. 1 is a graph showing the relationship between the concentration of ACE inhibitory peptide of sea buckthorn and inhibitory activity;
FIG. 2 is a graph of inhibition of ACE kinetics by sea buckthorn oligopeptide with double inversions;
FIG. 3 is a diagram showing the ACE inhibitory rate change state of sea buckthorn oligopeptide treated at different temperatures;
FIG. 4 is a diagram showing the change of ACE inhibition rate of sea buckthorn oligopeptide treated at different pH values;
fig. 5 is a total ion flow diagram of the hippophae rhamnoides oligopeptide component.
Detailed Description
The invention is further described in the following by the embodiments in conjunction with the drawings:
in this example, the preparation of the hippophae rhamnoides seed meal ACE inhibitory peptide:
Step 3, membrane separation and decoloration: the sea-buckthorn protein hydrolysate is passed through ultrafiltration membrane to obtain components below 2000Da, and the components are desalted and low molecular weight impurity is removed by nanofiltration membrane, the separated liquid is decolorized by active carbon fiber (500L distilled water is mixed with 10 inch active carbon fiber) for 1h, and then concentrated and spray dried to obtain sea-buckthorn ACE inhibitory peptide.
Characteristic study:
1. determination of ACE inhibition and IC50
Three test tubes were prepared with borate buffer solution having a pH of 8.3, HHL solution of 8mM and ACE solution of 0.1U/mL, and the reagents were added to the test tubes according to the parameters shown in Table 1 to react with each other. After the reaction was completed, 1.7mL of ethyl acetate was added to each tube, followed by shaking for 20s and allowing to stand for liquid separation. The ethyl acetate layer (1 mL) was taken out and placed in a drying oven at a constant temperature of 120 ℃ to dry for 30min. After drying, taking out the test tube, adding 3mL of ultrapure water for redissolving, adjusting the ultraviolet spectrophotometer at 228nm, and measuring the light absorption value of the redissolved solution, wherein the calculation formula is as follows:
in the formula: a. The B : the light absorption value of the control tube; a. The A : the light absorption value of the sample tube; a. The C : absorbance of blank tube
TABLE 1 sample addition for the test for determining ACE inhibition
The ACE inhibition rate of the sea buckthorn oligopeptide is calculated to be 84.98%, the relationship between the concentration of the ACE inhibition peptide of the sea buckthorn seed meal and the inhibition rate is shown in figure 1, the concentration of the ACE inhibition peptide and the inhibition activity show a positive correlation trend, and the IC50 of 4.358mg/mL can be calculated according to a relationship curve.
2. Calculation of inhibition constants Km and Vmax
The sea-buckthorn polypeptide prepared by the invention is diluted to 19.5, 9.75 and 0mg/mL, and the three concentrations of enzymolysis liquid react with HHL of 8.0, 4.0, 2.0 and 0.8mmol/L respectively. Measuring the reaction rate, taking 1/V as an ordinate and 1/[ S ] as an abscissa, making a Lineweaver-Burk double reciprocal diagram, analyzing an inhibition mode, and calculating inhibition constants Km and Vmax through the intercept of a straight line and the abscissa.
The kinetic pattern of ACE inhibition by the polypeptides was analyzed according to figure 2. The straight line of reciprocal double of sea buckthorn oligopeptide is crossed with the 1/[ S ] axis, which shows that the inhibition type of sea buckthorn oligopeptide belongs to non-competitive inhibition. The result proves that the sea buckthorn oligopeptide has no competitive relationship with a substrate, can be combined with an ACE-HHL complex or a site except an ACE active site, changes the spatial conformation of ACE and reduces the activity of the ACE. The intercept of the horizontal and vertical coordinates shows that Vmax of the sea-buckthorn oligopeptides of 19.5, 9.75 and 0 mmol/L are respectively 0.015, 0.008 and 0.006, km is 4.29 x 10 < -3 > mol/L, and as can be seen from FIG. 2, the ACE inhibition rate and the concentration of the sea-buckthorn oligopeptides have positive correlation change, and the higher the concentration of the sea-buckthorn oligopeptides is, the higher the inhibition rate is, and the stronger the inhibition capacity is.
3. Studies on the stability of sea-buckthorn oligopeptide
The sea-buckthorn oligopeptide prepared by the method is subjected to stability research, (1) the thermal stability research: and (3) carrying out water bath on the peptide liquid in a water bath kettle at the temperature of 4, 20, 40, 60, 80 and 100 ℃ for 2h, cooling to room temperature, and determining the ACE inhibition rate of the peptide. (2) pH stability study: the pH of the peptide solution is 2, 4, 6, 8, 10 and 12, the peptide solution is kept at 37 ℃ for 2 hours, the pH is adjusted to 8.3, and the ACE inhibition rate of the peptide is measured. (3) stability of digestive tract: weighing 0.1g of peptide freeze-dried powder, dissolving in 0.1M HCL solution to prepare 1% (w/v) solution, adjusting the pH to 2, adding 1% (w/w) pepsin, hydrolyzing for 3h at 37 ℃, inactivating the enzyme for 15min in boiling water bath, adjusting the pH of an enzymolysis system to 8 by using 1M NaOH, adding 1% (w/w) trypsin, hydrolyzing for 3h at 37 ℃, inactivating the enzyme in boiling water bath, and determining the ACE inhibition rate of the final enzymolysis system.
As can be seen from the results of measuring the inhibition rates of the sea buckthorn oligopeptides treated for 2 hours at different temperatures and at different pH values in the graphs of FIG. 3 and FIG. 4, the inhibition rates are not greatly changed, and the sea buckthorn oligopeptides have good thermal stability and pH stability. If the small peptide is applied to industrial production, the small peptide is completely feasible, and the structure of the small peptide is not easily damaged by acid, alkali and high temperature conditions.
The peptide was digested with pepsin and trypsin, and it was found that the ACE inhibition of 1% (w/v) peptide solution after digestion was 67.46 ± 3.83%, and that the ACE inhibition of undigested peptide solution of the same concentration was 70.24 ± 2.06%, which was slightly higher than the ACE inhibition of the digested peptide. This is because the polypeptide is enzymatically digested by pepsin and trypsin, the structure is destroyed, and it becomes an inactive fragment. Therefore, the sea buckthorn seed meal ACE inhibitory peptide still has good inhibitory capacity after digestion, which is related to the fact that the inhibitory peptide contains a large number of hydrophobic residues, and the more the content of the hydrophobic residues, the stronger the inhibitory activity of the peptide can be kept.
4. Sea-buckthorn oligopeptide amino acid composition research and peptide segment characteristic detection
Taking a certain amount of sea buckthorn oligopeptide sample, hydrolyzing the sample for 22 hours at 110 ℃ by using 6M HCL, taking out the sample, neutralizing the sample by using NaOH, filtering and centrifuging the sample, and taking supernatant for determination. High performance liquid chromatograph parameters, chromatographic conditions: the column temperature is 40 ℃; the flow rate is stabilized at 1.0mL/min; ultraviolet detector conditions: wavelength 338nm; the wavelength is changed to 262nm at 22.5 min; fluorescence detector conditions: excitation wavelength is 340nm, and emission wavelength is 450nm;22.5 The excitation wavelength was changed at min to 266nm and the emission wavelength was 305nm.
According to the analysis of the table 2, the sea buckthorn seed meal polypeptide is rich in amino acid types, comprises 17 amino acids, the total amount of the amino acids is 53.61g/100g, wherein 27.88% of 8 essential amino acids are contained, the content of the amino acids is more glutamic acid, arginine and aspartic acid, the content of the three amino acids reaches 55.47% of the total amount, and methionine and cystine are limited amino acids. According to the amino acid properties, the classification and comparison show that the acidic amino acid has 39.33 percent with the largest percentage, the hydrophobic amino acid is used next, the content is 29.24 percent, the basic amino acid and the neutral amino acid have low contents, respectively accounting for 20.92 percent and 11.27 percent, the aromatic amino acid has the smallest content, only accounting for 5.88 percent, and the positively charged amino acids such as lysine, tyrosine, phenylalanine and proline also account for 2 to 4 percent of the total amount.
TABLE 2 amino acid composition analysis table for sea buckthorn oligopeptide
Adopting a three-in-one ultrahigh resolution liquid chromatography-mass spectrometer to identify peptide fragments, wherein the capillary liquid chromatography conditions are as follows: and (3) analyzing the column: mobile phase A:0.1% formic acid; mobile phase B:0.1% formic acid and 80% acetonitrile; flow rate: 300nL/min. Mass spectrum conditions: primary mass spectrum parameters: resolution:60000; AGC target:4.0e5; maximum IT: 100ms; scanning range:375 to 1500; secondary mass spectrum parameters: resolution:15000; AGC target: 5.0e4; maximum IT:256ms; scan range Mode Auto: m/z Normal; HCD Collision Energy (%): 30. the peptide characterization calculation website (https:// pepcalc. Com) was used to calculate the isoelectric point (pI), net charge, and solubility of the polypeptide.
The results of the assay using the NCBI of ACE inhibitory peptides, uniprot database alignment were shown in fig. 5 and table 3 for 10 ACE inhibitory peptides. The molecular weight distribution of the peptide fragments measured at this time is between 1000 and 3000Da, wherein the molecular weight of the peptide fragments AGGGGGGGGGGSRRL and DDEARINQLFL is smaller and slightly larger than 1kDa, and the rest detected peptide fragments are larger than 1.5kDa, because most of the peptide fragments obtained by enzymolysis are not recorded in a database, so that the result is not detected. From these results, it can be seen that most of the 10 peptides contained hydrophobic amino acids at the C-terminus or N-terminus, or positively charged amino acid residues, and also contained a large amount of hydrophobic and aromatic amino acids. In addition, the existing research shows that arginine in the peptide can also improve the ACE inhibitory activity of the peptide, and most of peptide fragments screened at this time contain arginine, which has similar results with the amino acid sequences of ACE inhibitory peptides screened in other researches.
TABLE 3 detection results and physicochemical characteristics of peptide fragments
Serial number | Amino acid sequence | Mass to charge ratio | Isoelectric point | Static charge | Solubility in |
1 | FRVAWTEKNDGQRAPLANN | 2187.105 | pH9.86 | 1 | |
2 | LIISVAYARVAKKLWLCNMIGDVTTEQY | 3198.705 | pH8.7 | 0.9 | Poor |
3 | VIRSRASDGCLEVKEFEDIPP | 2360.191 | pH4.16 | -2.1 | |
4 | AGGGGGGGGGGSRRL | 1172.588 | pH12.1 | 2 | Good |
5 | LQPREGPAGGTTALREELSLGPEAALDTPPAGP | 3268.681 | pH3.88 | -3 | |
6 | DDEARINQLFL | 1333.675 | pH3.54 | -2 | Good |
7 | FAVSTLTSYDWSDRDDATQGRKL | 2632.264 | pH4.19 | -1 | |
8 | RQLSLEGSGLGVEDLKDN | 1929.988 | pH3.93 | -2 | Good |
9 | GGGGGGGGGGGGGGGIGGGGGGGGGGGAR | 1841.798 | pH10.84 | 1 | |
10 | KEALGEGCFGNRIDRIGDVSGMGCNRRTPAP | 3276.578 | pH8.07 | 0.9 | Good |
Through a peptide characteristic calculation website, the 10 peptides are shown to have wide isoelectric point distribution range, the isoelectric points are distributed between pH 3-12, the electrostatic charge is distributed between-2.1 and 2, the peptide segment 2 has poor solubility, and the solubility of most of the peptides is good, which shows that the peptides can be used as the auxiliary materials or raw materials of powder or infusion type health care products for processing and production due to the good solubility of the peptides.
The present invention has been described in detail, and it should be understood that the detailed description and specific examples, while indicating the preferred embodiment of the invention, are intended for purposes of illustration only and are not intended to limit the scope of the invention.
Claims (4)
1. A preparation method of sea buckthorn oligopeptide with ACE inhibitory activity is characterized by comprising the following steps: the method for obtaining the sea buckthorn ACE inhibitory peptide by taking sea buckthorn seed meal as a raw material through enzymolysis and membrane separation specifically comprises the following steps:
step 1, raw material pretreatment: micronizing fructus Hippophae seed meal to obtain fructus Hippophae seed powder, and mixing with water to obtain semen Hippophae powder suspension;
step 2, proteolysis: heating the sea-buckthorn seed powder suspension to 50-60 ℃, adjusting the pH to 9.5-10.5, and adding alkaline protease accounting for 1% of the mass of the sea-buckthorn seed powder for hydrolysis; after the hydrolysis is finished, respectively adding neutral protease accounting for 1 percent of the mass of the sea buckthorn seed powder and laccase accounting for 0.05 percent of the mass of the sea buckthorn seed powder for continuous hydrolysis; inactivating enzyme after hydrolysis, and centrifuging to obtain supernatant as fructus Hippophae protein hydrolysis solution;
step 3, membrane separation and decoloration: the method comprises the steps of enabling a sea-buckthorn protein hydrolysis solution to pass through an ultrafiltration membrane to obtain components below 2000Da, removing salt and small molecular weight impurities through a nanofiltration membrane, decoloring separated liquid through activated carbon fibers, concentrating, and performing spray drying to obtain sea-buckthorn ACE inhibitory peptide.
2. The method of preparing hippophae rhamnoides oligopeptide with ACE inhibitory activity according to claim 1, wherein the method comprises the following steps: in the step 1, the sea buckthorn seed meal is subjected to superfine grinding and is sieved by a 100-mesh sieve to obtain sea buckthorn seed powder, and then the sea buckthorn seed powder is mixed with water according to the weight ratio of 1:10 in proportion.
3. The method of preparing hippophae rhamnoides oligopeptide with ACE inhibitory activity according to claim 1, wherein the method comprises the following steps: in step 2, alkaline protease with model number AP200 is used for hydrolysis for 5h, and neutral protease with model number EF108 and laccase are added for continuous hydrolysis for 3h.
4. The method of preparing hippophae rhamnoides oligopeptide with ACE inhibitory activity according to claim 1, wherein the method comprises the following steps: in the step 3, the activated carbon fiber is prepared by matching 500L of distilled water with 10 inches of activated carbon fiber, and the decoloring time is 1h.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211087975.3A CN115232852A (en) | 2022-09-07 | 2022-09-07 | Preparation method of sea buckthorn oligopeptide with ACE (angiotensin converting enzyme) inhibitory activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211087975.3A CN115232852A (en) | 2022-09-07 | 2022-09-07 | Preparation method of sea buckthorn oligopeptide with ACE (angiotensin converting enzyme) inhibitory activity |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115232852A true CN115232852A (en) | 2022-10-25 |
Family
ID=83682118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211087975.3A Pending CN115232852A (en) | 2022-09-07 | 2022-09-07 | Preparation method of sea buckthorn oligopeptide with ACE (angiotensin converting enzyme) inhibitory activity |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115232852A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009125071A2 (en) * | 2008-04-11 | 2009-10-15 | Aromtech Ltd | Extract with high amount of bioactive components, and its use |
CN108277248A (en) * | 2017-12-29 | 2018-07-13 | 磐安县派普特生物科技有限公司 | A kind of method of ultrasonic wave extraction active seabuckthorn polypeptide |
CN109652271A (en) * | 2019-02-18 | 2019-04-19 | 林道新 | A kind of production method of health care Spondias axillaris fruit wine |
CN114517218A (en) * | 2020-11-19 | 2022-05-20 | 巫世贵 | Sea-buckthorn oligopeptide powder and preparation method and application thereof |
-
2022
- 2022-09-07 CN CN202211087975.3A patent/CN115232852A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009125071A2 (en) * | 2008-04-11 | 2009-10-15 | Aromtech Ltd | Extract with high amount of bioactive components, and its use |
CN108277248A (en) * | 2017-12-29 | 2018-07-13 | 磐安县派普特生物科技有限公司 | A kind of method of ultrasonic wave extraction active seabuckthorn polypeptide |
CN109652271A (en) * | 2019-02-18 | 2019-04-19 | 林道新 | A kind of production method of health care Spondias axillaris fruit wine |
CN114517218A (en) * | 2020-11-19 | 2022-05-20 | 巫世贵 | Sea-buckthorn oligopeptide powder and preparation method and application thereof |
Non-Patent Citations (2)
Title |
---|
张程慧等: "沙棘的综合价值研究进展", 食品工业科技, vol. 38, no. 22, 1 August 2017 (2017-08-01), pages 331 - 335 * |
黄鹏等: "沙棘生物活性肽的制备及功效研究", 食品与机械, vol. 26, no. 6, 18 November 2010 (2010-11-18), pages 67 - 69 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9609883B2 (en) | Method for producing wheat glutamine peptide | |
US20120302731A1 (en) | Protein hydrolysate, polypeptide solution and polypeptide, preparation method and use thereof | |
Xingfei et al. | Properties of ACE inhibitory peptide prepared from protein in green tea residue and evaluation of its anti-hypertensive activity | |
CN112626155B (en) | Preparation method of pea peptide | |
AU2020103832A4 (en) | Ginkgo Protein-derived Angiotensin I-converting enzyme (ACE) Inhibitory Peptide Composition and the Preparation Method and Application | |
CN112410393B (en) | Cannabis bioactive peptide and preparation method and application thereof | |
CN109022527A (en) | A kind of quinoa polypeptide and preparation method thereof with hypotensive activity | |
CN106472817A (en) | A kind of bird's nest polypeptide and preparation method thereof | |
CN106008669B (en) | A kind of hazelnut ace inhibitory peptide and preparation method thereof | |
CN110923284B (en) | Walnut nut flavor peptide and preparation method thereof | |
CN115232852A (en) | Preparation method of sea buckthorn oligopeptide with ACE (angiotensin converting enzyme) inhibitory activity | |
KR101433239B1 (en) | Preparation method for water soluble rice peptide | |
CN106480143A (en) | A kind of Lepidinm meyenii Walp oligosaccharide polypeptide and preparation method thereof | |
Liu et al. | Progress in the preparation, identification and biological activity of walnut peptides | |
US20220257705A1 (en) | Ace inhibitory peptide composition derived from ginkgo protein and preparation method and application thereof | |
CN107760747A (en) | A kind of industrialized production earthworm protein active peptide and preparation method | |
CN113881744A (en) | Method for preparing salty peptides by subcritical water assisted enzymolysis of mucedin | |
CN114990181A (en) | Anti-aging soybean peptide and preparation method and application thereof | |
CN109576330B (en) | Prunus bungeana seed polypeptide and preparation method and application thereof | |
KR20220043706A (en) | Method for preparing hydrolyzate of Tenebrio molitor protein using NURUK and protease, and hydrolyzate of Tenebrio molitor protein with enhanced antioxidant content | |
CN114907448B (en) | Daylily flavor peptide and preparation method and application thereof | |
Wu | Advances in the production and functional properties of corn protein peptides | |
CN114752644B (en) | Preparation method of red bean polypeptide with antioxidant effect | |
CN117462649B (en) | Royal jelly active peptide composition with ACE inhibition effect, and preparation method and application thereof | |
CN117482209B (en) | Queen bee embryo active peptide composition with ACE inhibition effect, and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |